Effect of Blood Flow Restriction on Football-Related Performance Parameters
NCT ID: NCT05452109
Last Updated: 2024-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2022-12-12
2023-10-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Blood Flow Restriction Training in Basketball Players
NCT06420362
Acute Effect of Blood Flow Restricted High-Intensity Resistive Training
NCT05274542
Arterial Stiffness Intercostal Muscle Oxygenation and Aerobic-Anaerobic Capacity in Elite American Football Players
NCT07319962
Effectiveness of Blood Flow Restricting Exercises and Isokinetic Exercises in Female Football Players
NCT06445478
The Effects of the Blood Flow Restriction Method on Performance Parameters in Elite Volleyball Players
NCT07019168
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blood Flow Restriction + Classical Training
Blood Flow Restriction
Blood flow restriction with low load (30-50% 1RM) for 2 sessions in a week for 6 weeks during classical training will be applied.
Classical Training Alone
Classical Training Alone
Classical training same as Group 1with moderate to high load (70-90% 1RM) for 2 sessions in a week for 6 weeks will be applied without blood restriction.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood Flow Restriction
Blood flow restriction with low load (30-50% 1RM) for 2 sessions in a week for 6 weeks during classical training will be applied.
Classical Training Alone
Classical training same as Group 1with moderate to high load (70-90% 1RM) for 2 sessions in a week for 6 weeks will be applied without blood restriction.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Volunteer to participate in the study
* Playing football in one of the clubs in Istanbul for at least 1 year
* Being in the pre-season of the club
* Absence of any ongoing musculoskeletal problems that limit exercising
Exclusion Criteria
* History of sports injury in the last 6 months
* Orthopedic lower extremity surgery in the last 1 year
* Body mass index ≥ 30 kg/m2
18 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul University - Cerrahpasa
OTHER
Biruni University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Begum Kara Kaya
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ayse Zengin Alpözgen, PhD
Role: STUDY_CHAIR
Istanbul University - Cerrahpasa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Biruni University
Istanbul, , Turkey (Türkiye)
Istanbul University Cerrahpasa
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DrTez
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.